Overview
Biguanide diabetes drug studied for healthspan.
- Endogenously produced or biosynthesized molecule
- Standardized pharmaceutical- or food-grade supplement
- Combined with cofactors that improve absorption or activity
- Capsule or softgel
- Powder
- Sublingual or buccal
- Liposomal liquid
Mechanism of action
Inhibits mitochondrial complex I; activates AMPK.
- · Inhibits mitochondrial complex I
- · activates AMPK
Effects on the body
Organ system effects
Metformin (Longevity Use) acts on hallmarks of aging including oxidative stress, mitochondrial dysfunction, and senescence signaling.
Metformin (Longevity Use) affects hepatic insulin sensitivity, lipid handling, or glucose disposal.
Evidence-based benefits
May reduce age-related diseases
Moderate evidencePotential side effects
- · GI upset
- · B12 deficiency
- · Lactic acidosis (rare)
Drug interactions
Supplement interactions
- NAD+ precursor (NMN or NR)Complementary mitochondrial and sirtuin support.
- Omega-3Lowers inflammation and supports membrane integrity.
No specific avoidances listed.
Dosing & bioavailability
Where to buy
Affiliate links — we may earn a commission at no extra cost to you. Amazon code supplementsch-20 is auto-applied at checkout. We don't endorse specific brands; verify third-party testing (USP, NSF, Informed Sport) before purchase.
Scientific evidence8Show studiesHide studies
Metformin in non-diabetics (TAME-related)
Bannister CA, et al.
78,000+ adults
Diabetics on metformin had lower mortality than matched non-diabetics.
PubMed: Metformin (Longevity Use) — May reduce age-related diseases
Live PubMed search
Live results for "Metformin (Longevity Use) May reduce age-related diseases" across the PubMed/MEDLINE peer-reviewed index.
Opens current human and preclinical literature matching Metformin (Longevity Use) and "May reduce age-related diseases". Filter by RCT, meta-analysis, or year on the results page.
PubMed: Metformin (Longevity Use) — randomized controlled trial
Live PubMed search
Live results for "Metformin (Longevity Use) randomized controlled trial" across the PubMed/MEDLINE peer-reviewed index.
Opens current human and preclinical literature matching Metformin (Longevity Use) and "randomized controlled trial". Filter by RCT, meta-analysis, or year on the results page.
PubMed: Metformin (Longevity Use) — meta-analysis
Live PubMed search
Live results for "Metformin (Longevity Use) meta-analysis" across the PubMed/MEDLINE peer-reviewed index.
Opens current human and preclinical literature matching Metformin (Longevity Use) and "meta-analysis". Filter by RCT, meta-analysis, or year on the results page.
PubMed: Metformin (Longevity Use) — pharmacokinetics
Live PubMed search
Live results for "Metformin (Longevity Use) pharmacokinetics" across the PubMed/MEDLINE peer-reviewed index.
Opens current human and preclinical literature matching Metformin (Longevity Use) and "pharmacokinetics". Filter by RCT, meta-analysis, or year on the results page.
PubMed: Metformin (Longevity Use) — safety adverse events
Live PubMed search
Live results for "Metformin (Longevity Use) safety adverse events" across the PubMed/MEDLINE peer-reviewed index.
Opens current human and preclinical literature matching Metformin (Longevity Use) and "safety adverse events". Filter by RCT, meta-analysis, or year on the results page.
PubMed: Metformin (Longevity Use) — dose response
Live PubMed search
Live results for "Metformin (Longevity Use) dose response" across the PubMed/MEDLINE peer-reviewed index.
Opens current human and preclinical literature matching Metformin (Longevity Use) and "dose response". Filter by RCT, meta-analysis, or year on the results page.
Google Scholar: Metformin (Longevity Use) — clinical evidence
Live Scholar search
Cross-database citation index for Metformin (Longevity Use) as it relates to "clinical evidence".
Includes preprints, theses, and journal articles. Useful for tracking citation counts and follow-on work.